1998
DOI: 10.1021/bi980026r
|View full text |Cite
|
Sign up to set email alerts
|

The Role of Gly-4 of Human Cystatin A (Stefin A) in the Binding of Target Proteinases. Characterization by Kinetic and Equilibrium Methods of the Interactions of Cystatin A Gly-4 Mutants with Papain, Cathepsin B, and Cathepsin L

Abstract: The importance of the evolutionarily conserved Gly-4 residue for the affinity and kinetics of interaction of cystatin A with several cysteine proteinases was assessed by site-directed mutagenesis. Even the smallest replacement, by Ala, resulted in approximately 1000-, approximately 10- and approximately 6000-fold decreased affinities for papain, cathepsin L, and cathepsin B, respectively. Substitution by Ser gave further 3-8-fold reductions in affinity, whereas the largest decreases, >10(5)-fold, were observed… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

5
62
1

Year Published

2000
2000
2017
2017

Publication Types

Select...
5
3

Relationship

1
7

Authors

Journals

citations
Cited by 38 publications
(68 citation statements)
references
References 46 publications
5
62
1
Order By: Relevance
“…This is the first known report of the functional expression of recombinant human stefin A in mammalian cells. The expression of functional recombinant human stefin A in E. coli has been previously reported (18)(19). However, in most cases the proteins expressed were stefin A fusion protein containing N-terminal extensions.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…This is the first known report of the functional expression of recombinant human stefin A in mammalian cells. The expression of functional recombinant human stefin A in E. coli has been previously reported (18)(19). However, in most cases the proteins expressed were stefin A fusion protein containing N-terminal extensions.…”
Section: Discussionmentioning
confidence: 99%
“…The expression of functional recombinant human stefin A in E. coli has been previously reported (18)(19)(20). However, the proteins expressed were fusion proteins containing N-terminal extensions or tags.…”
Section: Introductionmentioning
confidence: 99%
“…Cathepsins are strongly inhibited by cystatins in cells and in extracellular fluids (32). We investigated whether DNA influenced the reaction between cathepsin V and cystatin A (33), since the mode of interaction between cathepsins and cystatins is entirely different from that seen with serpins. In particular, cystatins do not interact directly with the catalytic residues of cysteine proteases and instead occlude the active site, preventing access to substrates.…”
Section: Involvement Of a Templating Mechanism In The Increase Of Catmentioning
confidence: 99%
“…The ϩCys-cystatin A variant, having an extra Cys at the N-terminus, was expressed with a His-tag, and purified essentially as in previous work~Pol et al, 1995;Estrada et al, 1998!, although with minor modifications due to the presence of the free cysteine residue. As the formation of dimers, like those seen with cystatin B Turk et al, 1992!, might have interfered with the cleavage of the His-tag by enterokinase, the protein was treated with DTT before incubation with the enzyme.…”
Section: Expression and Labelingmentioning
confidence: 99%
“…However, such truncation does not affect the rate of complex formation with these proteinases, indicating that the N-terminal region is not necessary for the fast association of the two molecules~Lindahl et al., 1992b;Björk et al, 1994;Estrada et al, 1999!. The N-terminal region may thus bind to proteinases with accessible active sites subsequent to the other binding regions in a reaction that was not detected by the kinetics studies. However, interaction of the N-terminal region with cathepsin B appears to precede and facilitate the displacement of the occluding loop in the binding of cystatins to this enzyme~Björk et al, 1994enzyme~Björk et al, , 1995enzyme~Björk et al, , 1996Nycander et al, 1998!. In this work, we have used the efficient expression system developed for the production of human cystatin A~Pol et al, 1995;Estrada et al, 1998! to express a variant of the inhibitor with an extra cysteine residue before the N-terminal methionine residue of the wild-type protein.…”
mentioning
confidence: 99%